Nigro-caudate dopaminergic deafferentation: A marker of REM sleep behavior disorder?

Neurobiology of Aging

Volumn 36, Issue 12, 2015, Pages 3300-3305

  Arnaldi, Dario ^a   De Carli, Fabrizio ^b   Picco, Agnese ^a   Ferrara, Michela ^a   Accardo, Jennifer ^a   Bossert, Irene ^a   Famà, Francesco ^a   Girtler, Nicola ^a   Morbelli, Silvia ^a   Sambuceti, Gianmario ^a   Nobili, Flavio ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b CNR   (Italy)

Author keywords

Parkinson's disease; REM sleep behavior disorder; SPECT

Indexed keywords

DOPAMINE TRANSPORTER; IOFLUPANE I 123; BIOLOGICAL MARKER; DOPAMINE;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; COGNITIVE DEFECT; CONTROLLED STUDY; DEAFFERENTATION; DISEASE CLASSIFICATION; DISEASE DURATION; DISEASE SEVERITY; DOPAMINERGIC TRANSMISSION; FEMALE; GERIATRIC DEPRESSION SCALE; HUMAN; MALE; MINI MENTAL STATE EXAMINATION; NIGRONEOSTRIATAL SYSTEM; PARASOMNIA; PARKINSON DISEASE; PHENOTYPE; POLYSOMNOGRAPHY; PRIORITY JOURNAL; PUTAMEN; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TOPOGRAPHY; UNIFIED PARKINSON DISEASE RATING SCALE; CAUDATE NUCLEUS; COMPLICATION; METABOLISM; MIDDLE AGED; REM SLEEP BEHAVIOR DISORDER; SEVERITY OF ILLNESS INDEX; SUBSTANTIA NIGRA; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BIOMARKERS; CAUDATE NUCLEUS; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; REM SLEEP BEHAVIOR DISORDER; SEVERITY OF ILLNESS INDEX; SUBSTANTIA NIGRA; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84947042182     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2015.08.025     Document Type: Article

References (38)

1. International Classification of Sleep Disorders, Revised: Diagnostic and Coding Manual 2001, AASM, American Academy of Sleep Medicine, Westchester , IL.
2. International Classification of Sleep Disorders - Second Edition (ICSD-2): Diagnostic and Coding Manual 2005, AASM, American Academy of Sleep Medicine, Westchester, IL. second ed.
3. International Classification of Sleep Disorders 2014, AASM, American Academy of Sleep Medicine, Darien, IL. third ed.
4. Albin R.L., Koeppe R.A., Chervin R.D., Consens F.B., Wernette K., Frey K.A., Aldrich M.S. Decreased striatal dopaminergic innervation in REM sleep behavior disorder. Neurology 2000, 55:1410-1412.
5. Arnaldi D., Campus C., Ferrara M., Fama F., Picco A., De Carli F., Accardo J., Brugnolo A., Sambuceti G., Morbelli S., Nobili F. What predicts cognitive decline in de novo Parkinson's disease?. Neurobiol. Aging 2012, 33:1127.e11-1127.e20.
6. Arnulf I. REM sleep behavior disorder: motor manifestations and pathophysiology. Mov. Disord. 2012, 27:677-689.
7. Boeve B.F. REM sleep behavior disorder: updated review of the core features, the REM sleep behavior disorder-neurodegenerative disease association, evolving concepts, controversies, and future directions. Ann. N. Y. Acad. Sci. 2010, 1184:15-54.
8. Boeve B.F. Idiopathic REM sleep behaviour disorder in the development of Parkinson's disease. Lancet Neurol. 2013, 12:469-482.
9. Boeve B.F., Molano J.R., Ferman T.J., Smith G.E., Lin S.C., Bieniek K., Haidar W., Tippmann-Peikert M., Knopman D.S., Graff-Radford N.R., Lucas J.A., Petersen R.C., Silber M.H. Validation of the Mayo Sleep Questionnaire to screen for REM sleep behavior disorder in an aging and dementia cohort. Sleep Med. 2011, 12:445-453.
10. Boeve B.F., Molano J.R., Ferman T.J., Lin S.C., Bieniek K., Tippmann-Peikert M., Boot B., St Louis E.K., Knopman D.S., Petersen R.C., Silber M.H. Validation of the Mayo Sleep Questionnaire to screen for REM sleep behavior disorder in a community-based sample. J. Clin. Sleep Med. 2013, 9:475-480.
11. Chahine L.M., Daley J., Horn S., Colcher A., Hurtig H., Cantor C., Dahodwala N. Questionnaire-based diagnosis of REM sleep behavior disorder in Parkinson's disease. Mov. Disord. 2013, 28:1146-1149.
12. Darcourt J., Booij J., Tatsch K., Varrone A., Vander Borght T., Kapucu O.L., Nagren K., Nobili F., Walker Z., Van Laere K. EANM procedure guidelines for brain neurotransmission SPECT using (123)I-labelled dopamine transporter ligands, version 2. Eur. J. Nucl. Med. Mol. Imaging 2010, 37:443-450.
13. Eisensehr I., Linke R., Noachtar S., Schwarz J., Gildehaus F.J., Tatsch K. Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder. Comparison with Parkinson's disease and controls. Brain 2000, 123(Pt 6):1155-1160.
14. Eisensehr I., Linke R., Tatsch K., Kharraz B., Gildehaus J.F., Wetter C.T., Trenkwalder C., Schwarz J., Noachtar S. Increased muscle activity during rapid eye movement sleep correlates with decrease of striatal presynaptic dopamine transporters. IPT and IBZM SPECT imaging in subclinical and clinically manifest idiopathic REM sleep behavior disorder, Parkinson's disease, and controls. Sleep 2003, 26:507-512.
15. Ferman T.J., Boeve B.F., Smith G.E., Lin S.C., Silber M.H., Pedraza O., Wszolek Z., Graff-Radford N.R., Uitti R., Van Gerpen J., Pao W., Knopman D., Pankratz V.S., Kantarci K., Boot B., Parisi J.E., Dugger B.N., Fujishiro H., Petersen R.C., Dickson D.W. Inclusion of RBD improves the diagnostic classification of dementia with Lewy bodies. Neurology 2011, 77:875-882.
16. Gagnon J.F., Bedard M.A., Fantini M.L., Petit D., Panisset M., Rompre S., Carrier J., Montplaisir J. REM sleep behavior disorder and REM sleep without atonia in Parkinson's disease. Neurology 2002, 59:585-589.
17. Gagnon J.F., Vendette M., Postuma R.B., Desjardins C., Massicotte-Marquez J., Panisset M., Montplaisir J. Mild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson's disease. Ann. Neurol. 2009, 66:39-47.
18. Gelb D.J., Oliver E., Gilman S. Diagnostic criteria for Parkinson disease. Arch. Neurol. 1999, 56:33-39.
19. Herz D.M., Eickhoff S.B., Lokkegaard A., Siebner H.R. Functional neuroimaging of motor control in Parkinson's disease: a meta-analysis. Hum. Brain Mapp. 2014, 35:3227-3237.
20. Iranzo A., Lomena F., Stockner H., Valldeoriola F., Vilaseca I., Salamero M., Molinuevo J.L., Serradell M., Duch J., Pavia J., Gallego J., Seppi K., Hogl B., Tolosa E., Poewe W., Santamaria J. Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study. Lancet Neurol. 2010, 9:1070-1077.
21. Iranzo A., Valldeoriola F., Lomena F., Molinuevo J.L., Serradell M., Salamero M., Cot A., Ros D., Pavia J., Santamaria J., Tolosa E. Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study. Lancet Neurol. 2011, 10:797-805.
22. Kim Y.K., Yoon I.Y., Kim J.M., Jeong S.H., Kim K.W., Shin Y.K., Kim B.S., Kim S.E. The implication of nigrostriatal dopaminergic degeneration in the pathogenesis of REM sleep behavior disorder. Eur. J. Neurol. 2010, 17:487-492.
23. Lai Y.Y., Hsieh K.C., Nguyen D., Peever J., Siegel J.M. Neurotoxic lesions at the ventral mesopontine junction change sleep time and muscle activity during sleep: an animal model of motor disorders in sleep. Neuroscience 2008, 154:431-443.
24. Miyamoto M., Miyamoto T., Iwanami M., Muramatsu S., Asari S., Nakano I., Hirata K. Preclinical substantia nigra dysfunction in rapid eye movement sleep behaviour disorder. Sleep Med. 2012, 13:102-106.
25. Nobili F., Campus C., Arnaldi D., De Carli F., Cabassi G., Brugnolo A., Dessi B., Morbelli S., Sambuceti G., Abbruzzese G., Rodriguez G. Cognitive-nigrostriatal relationships in de novo, drug-naive Parkinson's disease patients: a [I-123]FP-CIT SPECT study. Mov. Disord. 2010, 25:35-43.
26. Nobili F., Naseri M., De Carli F., Asenbaum S., Booij J., Darcourt J., Ell P., Kapucu O., Kemp P., Svarer C., Morbelli S., Pagani M., Sabri O., Tatsch K., Tossici-Bolt L., Sera T., Vander Borght T., VanLaere K., Varrone A. Automatic semi-quantification of [123I]FP-CIT SPECT scans in healthy volunteers using BasGan version 2: results from the ENC-DAT database. Eur. J. Nucl. Med. Mol. Imaging 2013, 40:565-573.
27. Parent A., Mackey A., De Bellefeuille L. The subcortical afferents to caudate nucleus and putamen in primate: a fluorescence retrograde double labeling study. Neuroscience 1983, 10:1137-1150.
28. Postuma R.B. Prodromal Parkinson's disease-using REM sleep behavior disorder as a window. Parkinsonism Relat. Disord. 2014, 20(Suppl 1):S1-S4.
29. Postuma R.B., Bertrand J.A., Montplaisir J., Desjardins C., Vendette M., Rios Romenets S., Panisset M., Gagnon J.F. Rapid eye movement sleep behavior disorder and risk of dementia in Parkinson's disease: a prospective study. Mov. Disord. 2012, 27:720-726.
30. Romenets S.R., Gagnon J.F., Latreille V., Panniset M., Chouinard S., Montplaisir J., Postuma R.B. Rapid eye movement sleep behavior disorder and subtypes of Parkinson's disease. Mov. Disord. 2012, 27:996-1003.
31. Rupprecht S., Walther B., Gudziol H., Steenbeck J., Freesmeyer M., Witte O.W., Gunther A., Schwab M. Clinical markers of early nigrostriatal neurodegeneration in idiopathic rapid eye movement sleep behavior disorder. Sleep Med. 2013, 14:1064-1070.
32. Schiess M.C., Zheng H., Soukup V.M., Bonnen J.G., Nauta H.J. Parkinson's disease subtypes: clinical classification and ventricular cerebrospinal fluid analysis. Parkinsonism Relat. Disord. 2000, 6:69-76.
33. Sixel-Doring F., Trautmann E., Mollenhauer B., Trenkwalder C. Associated factors for REM sleep behavior disorder in Parkinson disease. Neurology 2011, 77:1048-1054.
34. Stiasny-Kolster K., Doerr Y., Moller J.C., Hoffken H., Behr T.M., Oertel W.H., Mayer G. Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT. Brain 2005, 128(Pt 1):126-137.
35. Walker Z., Costa D.C., Walker R.W.H., Shaw K., Gacinovic S., Stevens T., Livingston G., Ince P., McKeith I.G., Katona C.L.E. Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand. J. Neurol. Neurosurg. Psychiatry 2002, 73:134-140.
36. Boccacci P., Bonetto P., Calvini P., Formiconi A.R. A simple model for the efficient correction of collimator blur in 3D SPECT imaging. Inverse Probl. 1999, 15:907-930.
37. Calvini P., Rodriguez G., Inguglia F., Mignone A., Guerra U.P., Nobili F. The basal ganglia matching tools package for striatal uptake semi-quantification: description and validation. Eur. J. Nucl. Med. Mol. Imaging 2007, 34:1240-1253.
38. Hudson H.M., Larkin R.S. Accelerated image reconstruction using ordered subsets of projection data. IEEE Trans. Med. Imaging 1994, 13:601-609.